Bio-Path Holdings, Inc.
BPTH · OTC
Bulios Fair Price
$0
100.0% downside
Trenutna cena
$0.0001
Po podatkih Bulios Fair Price je delnica BPTH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Bio-Path Holdings, Inc. (BPTH) is a biopharmaceutical company focused on developing drug candidates for the treatment of various types of cancer. Its main therapeutic platform includes liposomal delivery technology, which enables targeted delivery of therapeutic agents directly to cancer cells. The company primarily focuses on treating leukemia and various types of carcinomas, including breast, pancreatic, and lung cancers. Bio-Path Holdings conducts clinical trials and research to assess the efficacy of its drug candidates and their potential therapeutic benefits. Shares of Bio-Path Holdings, Inc. (BPTH) may be suitable for investors seeking opportunities in the biotechnology sector with a focus on innovative approaches to combating cancer.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Vikram Paul Grover
Employees
1
Headquarters
Bellaire
Prihajajoči dogodki
Earnings
Upcoming earnings report